HS-1200 Overcomes the Resistance Conferred by Bcl-2 in Human Leukemic U937 Cells

키워드

참고문헌 (37)

1. Tsujimoto Y, "Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma", Proc Natl Acad Sci USA, 83, pp.5214~5218 (1986)
2. Dasmahapatra G, "Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2", Mol Pharmacol, 69, pp.288~298 (2006)
3. Yin XM, "BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerzation with Bax", Nature, 369, pp.321~323 (1994)
4. Yin DX, "BCL-2 expression delays druginduced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells", Cancer Res, 55, pp.4922~4928 (1995)
5. Park JW, "Bcl- 2 overexpression attenuates cisplatin-induced apoptosis in U937 cells by inhibition of caspase-3 activity", Carcinogenesis, 22, pp.1633~1639 (2001)
6. Campos L, "High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy", Blood, 81, pp.3091~3096 (1993)
7. Lowenberg B, "Acute myeloid leukemia", N Engl J Med, 341, pp.1051~1062 (1999)
8. Smith M, "Adult acute myeloid leukaemia", Crit Rev Oncol Hematol, 50, pp.197~222 (2004)
9. Wang G, "Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)", Oncol Rep, 12, pp.955~965 (2004)
10. Blake J, "Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line", Am J Physiol, 275, pp.723~730 (1988)
11. Martinez JD, "Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation", Nutr Cancer, 31, pp.111~118 (1998)
12. Im EO, "A novel ursodeoxycholic acid derivative induces apoptosis in human MCF-7 breast cancer cells", Pharm Pharmacol Commun, 5, pp.293~298 (1999)
13. Im EO, "Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells", Cancer Lett, 163, pp.83~93 (2001)
14. Choi YH, "Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells", Cancer Lett, 199, pp.157~157 (2003)
15. Jeong JH, "Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1", Ann N Y Acad Sci, 1010, pp.171~177 (2003)
16. Seo SY, "Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin", Anticancer Drugs, 14, pp.219~225 (2003)
17. 박상은, "Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells", INTERNATIONAL JOURNAL OF ONCOLOGY, 25, pp.231~236, PROFESSOR D A SPANDIDOS
18. Im EO, "Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells", Cancer Lett, 229, pp.49~57 (2005)
19. Kim ND, "Modulation of the cell cycle and induction of apoptosis in human cancer cells by synthetic bile acids", Curr Cancer Drug Targets, 6, pp.681~689 (2006)
20. Hofmann TG, "Body language: the function of PML nuclear bodies in apoptosis regulation", Cell Death Differ, 10, pp.1290~1299 (2003)
21. Muratani M, "Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus", Nat Cell Biol, 4, pp.106~110 (2004)
22. Chelbi-Alix MK, "Induction of the PML protein by interferons in normal and APL cells", Leukemia, 9, pp.2027~2033 (1995)
23. Kakizuka A, "Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML", Cell, 66, pp.663~674 (1991)
24. Bernardi R, "Role of PML and the PMLnuclear body in the control of programmed cell death", Oncogene, 22, pp.9048~9057 (2003)
25. Salomoni P, "The role of PML in tumor suppression", Cell, 108, pp.165~170 (2002)
26. Pearson M, "PML interaction with p53 and its role in apoptosis and replicative senescence", Oncogene, 20, pp.7250~7256 (2001)
27. Negorev D, "Cellular proteins localized at and interacting within ND10", PML nuclear bodies, Oncogene, pp.2001, 20[DOI]
28. Li H, "PML and the oncogenic nuclear domains in regulating transcriptional repression", Curr Opin Cell Biol, 12, pp.641~644 (2000)
29. Lehembre F, "Regulation of Pax3 transcriptional activity by SUMO-1-modified PML", Oncogene, 20, pp.1~9 (2001)
30. Zhong S, "Role of SUMO-1-modified PML in nuclear body formation", Blood, 95, pp.2748~2752 (2000)
31. 최진, "Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway", Cancer Letters, 247(2), pp.213~223, Elsevier BV
32. Fogal V, "Regulation of p53 activity in nuclear bodies by a specific PML isoforms", EMBO J, 19, pp.6185~6195 (2000)
33. Bode AM, "Post-translational modification of p53 in tumorigenesis", Nat Rev Cancer, 4, pp.793~805 (2004)
34. Lallemand-Breitenbach V, "Role of promyelocytic leukemia (PML) SUMOlation in nuclear body formation, 11S proteasome recruitment, and As2O3- induced PML or PML", retinoic acid receptor alpha degradation, 2001, pp.193, 1361~1372
35. LaMorte VJ, "Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body", Proc Natl Acad Sci USA, 95, pp.4991~4996 (1998)
36. Zhu J, "Arsenic induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia", Proc Natl Acad Sci USA, 94, pp.3978~3983 (1997)
37. Gongora R, "An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons", Immunity, 14, pp.727~737 (2001)